NEUROSTECH has been awarded a R&D Grant (IDE/2021/000422) for the project entitled “Development of a new drug delivery device for clinical use” within the PID program RIS3 Empresa from the Government of Asturias´ innovation agency (IDEPA).
Activities include the design, manufacture and testing of an implantable intrathecal prototype under conditions that will enable its ulterior use in clinical research. The tasks encompass technical, regulatory and scalability aspects, as well as prototype testing to evalute functionality, tightness and biocompatibility.
